Blackstone Life Sciences is a segment of the private equity firm, The Blackstone Group. The firm invests in companies operating in the life science, pharma, medical device research, biotechnology, and healthcare sectors. The firm is a result of The Blackstone Group's acquisition of Clarus Ventures in 2018.